Myrtle Davis

Company: Bristol Myers Squibb

Job title: Vice President - Discovery Toxicology

Seminars:

Workshop B: Regulatory Expectations – Testing ADC Toxicity & Designing Experiments in Accordance to Obtain IND and BLA Approval 1:00 pm

With the common goal of developing ADCs with the highest therapeutic index, the industry is gradually shifting away from traditional ADCs and testing methods and towards novel approaches, such as a reduction in animal testing and newer payload and mechanistic technologies. From these advances, a question has to be asked – what are the regulatory…Read more

day: Workshop Day